The implications of Brexit for the pharmaceutical and medical devices industry in the long run will only really become apparent when the final model governing the UK’s new relationship with the EU is determined. It is at this stage difficult to predict how the withdrawal will be managed, and whether the UK government will trigger the Article 50 process immediately. We are likely to witness lengthy negotiations between the UK and the EU on the…